Thus, the inhibition of IL-6 can eliminate sensitive IL-6 clones of malignance cells creating free tumor environment niches, although favoring the proliferation of other malignant clone cells whose growth is triggered by other growth factors [55]. The gene discussed is IL6; the disease is neoplasm.